Work

P3‐254: Exebryl‐1: A novel small molecule currently in human clinical trials as a disease‐modifying drug for the treatment of Alzheimer's disease

Year: 2009

Type: article

Source: Alzheimer s & Dementia

DOI: 10.1016/j.jalz.2009.04.925

Authors: Alan D. Snow, Joel Cummings, Thomas Lake, Qubai Hu, Luke Esposito, Judy Cam, Michael Hudson, Elizabeth Smith, Steve Runnels

Institution: ProteoTech (United States)

Language: English

Topic: Alzheimer's disease research and treatments

Subfield: Physiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2019645370

FWCI: 1.103

Cites:

Cited by: 18

Related to: 10